UPDATE : Tuesday, June 18, 2019
상단여백
‘Expanded reimbursement for Prolia to give more options to osteoporosis patients’ by Lee Han-soo 2019-03-29 18:32
Phase-3 trials of Huntington’s chorea treatment approved by Lee Hye-seon 2019-03-29 17:24
Il-yang to research Parkinson’s disease in Europe by Lee Han-soo 2019-03-28 16:28
Allergan to resume marketing of macular edema treatment by Lee Han-soo 2019-03-27 16:55
JW Life Science wins nod for 3rd-generation nutrient infusion in Europe by Jeong Sae-im 2019-03-27 16:16
라인
FDA OKs CrystalGenomics’ P1 trial for leukemia treatment by Lee Han-soo 2019-03-27 15:58
‘Remimazolam has fewer side effects than propofol’ by Jeong Sae-im 2019-03-27 15:05
CJ Healthcare releases P3 trial results for gastroesophageal reflux treatment by Lee Han-soo 2019-03-27 14:52
AstraZeneca to launch Imfinzi in Korea next month by Lee Han-soo 2019-03-27 14:52
Hanlim Pharm seeks to expand HL301’s indication for radiation pneumonitis by Lee Hye-seon 2019-03-26 15:57
라인
Doctors outrageous over MSD Korea’s recordings of their talks by Park Gi-taek 2019-03-25 16:05
Daewoong releases P3 trial results for Nabota by Lee Han-soo 2019-03-25 15:01
Regulator OKs immunotherapies developed by multinational pharma companies by Lee Han-soo 2019-03-25 11:28
Otsuka Korea CEO receives presidential citation by Lee Han-soo 2019-03-22 16:52
Setback in search for Alzheimer’s drug: Biogen halts phase-3 aducanumab trials by Kim Yun-mi 2019-03-22 15:50
라인
Eubiologics gets nod to test botulinum toxin in phase-1 study by Lee Hye-seon 2019-03-22 15:28
‘MSD Korea excessively monitors workers, collects client info without consent’ by Jeong Sae-im 2019-03-22 13:49
AbClon, C&R Research sign CRO contract by Lee Han-soo 2019-03-21 17:17
2 drugs for enlarged prostate not different in depression risk by Lee Hye-seon 2019-03-21 16:51
SK Biopharmaceutical’s US partner gets FDA nod for sleepiness treatment by Lee Han-soo 2019-03-21 15:26
여백
여백
여백
Back to Top